Chronic Kidney Disease Global Market Report 2023

Description

“Chronic Kidney Disease Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic kidney disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic kidney disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chronic kidney disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy
2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments
3) By Route of Administration: Oral; Intravenous; Subcutaneous
4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users
Companies Mentioned: Pfizer Inc; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the chronic kidney disease market are: Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, and ProKidney Corp.

The global chronic kidney disease market is expected to grow from $61.51 billion in 2022 to $65.74 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chronic kidney disease market is expected to reach $82.96billion in 2027 at a CAGR of 6%.

The chronic kidney disease market consists of revenues earned by entities by providing peritoneal dialysis, in-center hemodialysis, and home hemodialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic kidney disease market also includes sales such as captopril, enalapril, finerenone, and fosinopril used during the treatment procedure. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Chronic kidney disease is characterized by the inability of damaged kidneys to efficiently filter blood, resulting in excess fluid and blood waste in the body, potentially leading to health problems. It is commonly caused by diabetes, high blood pressure, and obesity. It requires careful, ongoing management and has the potential to proceed to end-stage renal failure requiring dialysis or transplant.

North America was the largest region in the chronic kidney disease market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic kidney disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa

The main diagnostic tests for chronic kidney disease are blood tests, urine tests, imaging tests, and a kidney biopsy. A blood test refers to the scientific examination of a blood sample that will be examined medically. The various types of treatments include drugs, dialysis, kidney transplants, ACE inhibitors, blood tests, and others. These drugs are administered through oral, intravenous, and subcutaneous routes of administration, and are used by various end-users, such as hospitals and clinics, ambulatory surgery centers (ASCS), dialysis centers, and others.

The increasing prevalence of kidney disease is expected to propel the growth of the chronic kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Medication for kidney disease is used to control blood pressure in patients and decrease protein loss to halt the progression of kidney impairment, manage symptoms, and avoid consequences. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 15%, or 37 million people in the US, were affected by kidney disease. Furthermore, according to a report from the Australian Institute of Health and Welfare, an Australia-based Government agency, the prevalence of kidney replacement therapy in 2020 was 95.4 (per 100,000 population), up from 94 (per 100,000 population) in 2019. Therefore, the increasing prevalence of kidney disease is driving the growth of the chronic kidney disease market.

Product innovations are a key trend gaining popularity in the chronic kidney disease market. Companies operating in the chronic kidney disease market are developing innovative products to sustain their position in the market. For instance, in August 2022, Bayer, a Germany-based biotechnology and pharmaceutical company, launched the innovative medicine Kerendia (finerenone) to slow down the progression of chronic kidney disease in diabetes patients. It is a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist and differs from existing treatments. It blocks mineralocorticoid receptor (MR) overactivation, contributing to CKD progression and cardiovascular damage.

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. The acquisition will add CinCor's candidate medicine, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure control in treatment-resistant hypertension, to AstraZeneca's cardiorenal pipeline. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company that develops products to treat resistant and uncontrolled hypertension and chronic kidney disease.

The countries covered in the chronic kidney disease market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chronic kidney disease market research report is one of a series of new reports from The Business Research Company that provides chronic kidney disease market statistics, including the chronic kidney disease industry global market size, regional shares, competitors with a chronic kidney disease market share, detailed chronic kidney disease market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic kidney disease industry. This chronic kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Product Code: r8064

1. Executive Summary

2. Chronic Kidney Disease Market Characteristics

3. Chronic Kidney Disease Market Trends And Strategies

4. Chronic Kidney Disease Market - Macro Economic Scenario

4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Chronic Kidney Disease Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Chronic Kidney Disease Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Chronic Kidney Disease Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market

6. Chronic Kidney Disease Market Segmentation

6.1. Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Blood Test
Urine Test
Imaging Test
Kidney Biopsy
6.2. Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Drugs
Dialysis
Kidney Transplant
ACE Inhibitors
Blood Test
Other Treatments
6.3. Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Intravenous
Subcutaneous
6.4. Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital And Clinics
Ambulatory Surgery Centers (ASCs)
Dialysis Centers
Other End-Users

7. Chronic Kidney Disease Market Regional And Country Analysis

7.1. Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Chronic Kidney Disease Market

8.1. Asia-Pacific Chronic Kidney Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Chronic Kidney Disease Market

9.1. China Chronic Kidney Disease Market Overview
9.2. China Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Chronic Kidney Disease Market

10.1. India Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Chronic Kidney Disease Market

11.1. Japan Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Chronic Kidney Disease Market

12.1. Australia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Chronic Kidney Disease Market

13.1. Indonesia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Chronic Kidney Disease Market

14.1. South Korea Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Chronic Kidney Disease Market

15.1. Western Europe Chronic Kidney Disease Market Overview
15.2. Western Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Chronic Kidney Disease Market

16.1. UK Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Chronic Kidney Disease Market

17.1. Germany Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Chronic Kidney Disease Market

18.1. France Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Italy Chronic Kidney Disease Market

19.1. Italy Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Spain Chronic Kidney Disease Market

20.1. Spain Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. Eastern Europe Chronic Kidney Disease Market

21.1. Eastern Europe Chronic Kidney Disease Market Overview
21.2. Eastern Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. Russia Chronic Kidney Disease Market

22.1. Russia Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. North America Chronic Kidney Disease Market

23.1. North America Chronic Kidney Disease Market Overview
23.2. North America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. USA Chronic Kidney Disease Market

24.1. USA Chronic Kidney Disease Market Overview
24.2. USA Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Canada Chronic Kidney Disease Market

25.1. Canada Chronic Kidney Disease Market Overview
25.2. Canada Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. South America Chronic Kidney Disease Market

26.1. South America Chronic Kidney Disease Market Overview
26.2. South America Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Brazil Chronic Kidney Disease Market

27.1. Brazil Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

28. Middle East Chronic Kidney Disease Market

28.1. Middle East Chronic Kidney Disease Market Overview
28.2. Middle East Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

29. Africa Chronic Kidney Disease Market

29.1. Africa Chronic Kidney Disease Market Overview
29.2. Africa Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

30. Chronic Kidney Disease Market Competitive Landscape And Company Profiles

30.1. Chronic Kidney Disease Market Competitive Landscape
30.2. Chronic Kidney Disease Market Company Profiles
- 30.2.1. Pfizer Inc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson and Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Chronic Kidney Disease Market Other Major And Innovative Companies

31.1. Novartis International AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb Company
31.4. Abbott laboratories Inc.
31.5. GlaxoSmithKline PLC
31.6. Takeda Pharmaceuticals Ltd.
31.7. Eli Lilly and Company
31.8. Boehringer Ingelheim International GmbH
31.9. Amgen Inc.
31.10. Novo Nordisk AS
31.11. Siemens Healthineers AG
31.12. AstraZeneca Pharmaceuticals LP
31.13. Teva Pharmaceutical Industries Ltd.
31.14. Beckman Coulter Inc.
31.15. Kissei Pharmaceutical Co. Ltd.

32. Global Chronic Kidney Disease Market Competitive Benchmarking

33. Global Chronic Kidney Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Kidney Disease Market

35. Chronic Kidney Disease Market Future Outlook and Potential Analysis

35.1 Chronic Kidney Disease Market In 2027 - Countries Offering Most New Opportunities
35.2 Chronic Kidney Disease Market In 2027 - Segments Offering Most New Opportunities
35.3 Chronic Kidney Disease Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer